3396

antibody from Cell Signaling Technology, Inc

Targeting: ZEB1 AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a

Western blot (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Antibody Data

Product number

3396

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#3396, RRID:AB_1904164

Product name

ZEB1 (D80D3) Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human

Host

Rabbit

Storage

-20°C

References

Submitted references

Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.

Marín-Aguilera M, Codony-Servat J, Reig Ò, Lozano JJ, Fernández PL, Pereira MV, Jiménez N, Donovan M, Puig P, Mengual L, Bermudo R, Font A, Gallardo E, Ribal MJ, Alcaraz A, Gascón P, Mellado B
Molecular cancer therapeutics 2014 May;13(5):1270-84

---

MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.

Rajabi H, Alam M, Takahashi H, Kharbanda A, Guha M, Ahmad R, Kufe D
Oncogene 2014 Mar 27;33(13):1680-9

---

Acquired expression of NFATc1 downregulates E-cadherin and promotes cancer cell invasion.

Oikawa T, Nakamura A, Onishi N, Yamada T, Matsuo K, Saya H
Cancer research 2013 Aug 15;73(16):5100-9

---

SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.

Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, Kurasawa Y, Muramatsu T, Sugihara K, Inazawa J
Oncogene 2012 Nov 22;31(47):4923-34

---

Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.

Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, Settleman J, Johnson L
Cancer research 2012 Jan 15;72(2):527-36

---

Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT).

Grassian AR, Lin F, Barrett R, Liu Y, Jiang W, Korpal M, Astley H, Gitterman D, Henley T, Howes R, Levell J, Korn JM, Pagliarini R
The Journal of biological chemistry 2012 Dec 7;287(50):42180-94

---

Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells.

Kurasawa Y, Kozaki K, Pimkhaokham A, Muramatsu T, Ono H, Ishihara T, Uzawa N, Imoto I, Amagasa T, Inazawa J
Oncogene 2012 Apr 12;31(15):1963-74

---

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC
Nature cell biology 2011 Mar;13(3):317-23